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INTRODUCTION
 There is a pressing need for 
advancements in peripheral nerve repair 
techniques and recovery evaluation methods. 
High rates of peripheral nerve injury 
incidence combined with poor functional 
outcomes are the main drivers of novel 
research in this arena. In developed countries, 
between 13 and 23 per 100,000 new 
peripheral nerve injuries occur yearly [1]. 
Primarily young, active people suffer 
peripheral nerve damage, causing them to 
incur lifelong disability and loss of economic 
productivity for the remainder of their lives.  
      Although autografts are the current gold 
standard for peripheral nerve recovery, they 
frequently result in negative outcomes. 
Healthy nerves must be sacrificed from a 
limited availability of viable tissue [2]. At the 
harvest site, scarring, sensory loss, morbidity, 
and neuroma occur [3]. At the donor site, 
additional incisions are required to insert the 
autograft, further damaging debilitated tissue 
[1]. Incongruencies between nerves 
frequently result numbness and functional 
recovery far below expectations [2, 4]. 
      Other methods of repair such as 
allografts, mesh inserts, and muscle grafting 
do not show as promising results as recent 
advancements in tissue engineered conduits 
[1]. Improved and validated testing methods 
will determine the repair methods that result 
in the best functional return. 
      The rat sciatic nerve injury model is well 
examined in literature as a model for 
peripheral nerve repair. Histomorphological 
and electromyographic evaluations of nerve 
repair are common, and include axon counts, 
average axon diameter, motor unit counts, 
muscle weight, and muscle reinnervation via 
electromyograms [5, 6]. While useful in 
studying the processes of repair, it is well 
documented that these methods often do not 
correlate with functional outcomes [5, 6, 8].  
      Evaluation of the Sciatic Functional 
Index (SFI) is the current standard for 
functional through the analysis of the 
animal’s gait. Walking track analyses like 
SFI are favorable because they evaluate 
sensory and motor neuron functional return. 
SFI is calculated from footprint length and 
toe spread in the middle of the gait cycle [8]. 
While SFI is an accurate measure of 
functionality for rats with normal toe spread, 
its validity has been challenged in the 
presence of certain conditions. SFI fails in the 
presence of autotomy (self-mutilation) and 
toe contractures (toe curl) in which the rat 
may walk on only the heel of the foot or on 
top of its curled toes [9, 10]. In one study, 
80% of an experimental group exhibited toe 
contracture, decreasing the impact of the 
experiment [8]. Further, SFI fails to account 
for changes in velocity mid-trial and between 
rodents. Print length, the main component of 
SFI, has been shown to vary significantly 
with speed [11]. While there are other novel 
functional assessment methods in literature, 
validation is required to better evaluate the 
results and differences. No one test may 
universally indicate recovery, but further 
investigation can prove which are more 
accurate for certain targets and populations. 
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METHODS 
 
Experimental Design 
      The purpose of this study is to compare 
new walking track evaluation methods 
applied to a previous animal study. In the 
previous study, nanofiber conduits for 
peripheral nerve repair were evaluated in a rat 
sciatic model. Conduits were created from 
both aligned Arginylglycylaspartic acid-
poly(ε-caprolactone) (RGD-PCL) peptide 
functionalized nanofibers and non-
functionalized PCL control nanofibers, seen 
in Figure 1. Details regarding the creation of 
the nanofiber conduits and execution of the 
animal study are currently in submission 
[12].  
 
 
Figure 1. Image of the electrospun nanofibers 
prior to being functionalized provided by 
Cavanaugh et al., 2019 [12] 
 
The scope of this project entailed the 
functional assessment methods without 
handling any animals. In this IACUC-
approved study to model peripheral nerve 
repair, gaps were created in the sciatic nerves 
of male Lewis rats. One hind leg served as a 
sham and the other as an experimental. The 
rats were randomly assigned to four 
experimental groups for nerve repair, with 
five animals per group: repair via an isograft, 
an empty conduit (negative control), the 
RGD-PCL fiber and a PCL control fiber. 
Functional recovery was assessed through 
SFI biweekly. The current study served to 
retrospectively extract data to compare four 
walking track analysis methods:  
 
1. Sciatic Functional Index 
2. Imbalance Coupling 
3. Stance Factor 
4. Toe Out Angle 
 
While these tests were not novel 
individually, their side-by-side comparison 
has not been performed. I investigated these 
evaluation techniques to may reveal which 
are correlated, which are least subject to 
variation, and if any had the potential for a 
new industry standard for evaluating nerve 
repair. 
 
Sciatic Functional Index (SFI) 
Images were taken while the target 
foot was in midstance and the other foot was 
mid-swing in the gait cycle. Three measures 
were used to calculate SFI: print length, the 
distance from the heel to the third toe; toe 
spread, the distance from the first to the fifth 
toe; and intermediate toe spread, distance 
from the second to the fourth toe. A healthy 
SFI should hover near 0, while scores closer 
to -100 indicate total impairment. Examples 
of both healthy and impaired SFI can be seen 
in Figure 2. SFI is expressed as a ratio of the 
experimental foot measurements to the sham 
foot measurements. SFI was calculated by 
Equation 1, where PLF, TSF, and ITF are the 
percent change from sham to experimental 
print length, toe spread, intermediate toe 
spread [13]. 
 
SFI = (−38.3×PLF) + (109.5×TSF) + 
(13.3×ITF) −8.8          (1) 
 
Imbalance Coupling (IC) 
 Bozkurt, et al., 2011 [7] defined 
coupling as the “percentage of the step cycle 
of a certain paw (the anchor paw) at which 
the step cycle of another paw (the target paw) 
commences.” The gait cycle of a single foot 
commences with heel strike and is completed 
at the following heel strike of the same foot. 
This measure required a minimum of four 
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consecutive steps at a constant speed. A 
healthy score ranges from 0.48-0.52, 
indicating that a new step cycle begins 
halfway through the other foot’s cycle. 
Serradj and Jamon, 2009 [14], showed that 
hind and front leg coupling patterns vary 
significantly with walking speed. This 
functional measure should be independent of 
abnormal gait, autotomy, or toe contracture. 
IC was an individual measurement per foot. 
To compare IC to the other evaluation 
methods it was expressed as a ratio of the 
sham to experimental foot. Thus, the optimal 
value was 1, which indicated the 
experimental foot is equal to sham levels.  
 
 
Figure 2. Toe spread in a sham and 
experimental foot two weeks after sciatic  
nerve damage. The toe spread in the sham 
foot is representative of near 0 SFI, while the 
toe spread in the experimental foot is 
representative of near -100 SFI.  
 
Stance Factor (SF) 
Stance Factor is the ratio of the 
duration of ground contact between the 
uninjured and injured feet. required a 
minimum of four consecutive steps at a 
constant speed. This measure required a 
minimum of four consecutive steps at a 
constant speed. Stance factor is low for 
injured rats and steadily increases toward a 1 
with recovery, indicating the rats are 
spending equal amounts of time on each foot. 
This measure has been shown to correlate 
with SFI and is a good alternative because 
abnormal gait, autotomy, and toe contracture 
do not interfere with the measurement [11]. 
 
Toe Out Angle (TOA) 
 Toe out angle is the angle between the 
direction of progression and a reference line 
in through the heel of the foot and the third 
digit. Varejao et al., 2004 [10] noted this 
measure correlated well with SFI in 
measuring functional recovery. Healthy rats 
exhibit low angles of just a few degrees. The 
angle is expected to be higher post-injury and 
slowly decrease to pre-injury levels with 
healing. Increased toe out angle has been 
shown to correlate significantly with 
increased walking speed [14]. This measure 
is a good alternative to SFI because it can still 
be calculated in instances of autotomy and 
toe contracture. TOA was an individual 
measurement per foot. To compare TOA to 
the other evaluation methods it was 
expressed as a ratio of the sham to 
experimental foot. Thus, the optimal value 
was 1, which indicated the experimental foot 
is equal to sham levels. 
 
Statistical Analysis 
One way repeated measures ANOVA 
tests were conducted in Minitab® to view 
statistical significance for each evaluation 
method. Significance was considered p<0.05 
and can be found in Table 1. The first 
ANOVA test excluded week 12 to include the 
isograft group. The second ANOVA test 
excluded the isograft group to include week 
12. The factors were the week, treatment 
method, and subjects. Tukey pairwise 
comparison identified which groups caused 
significant differences been factors. A 
Pearson correlation was used to determine 
the correlation between evaluation 
techniques. A Pearson coefficient between 
the absolute values of 1 and 0.7 indicated a 
strong relationship. Significance was 
considered p<0.05. 
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RESULTS 
 
Walking track videos were obtained 
at 2, 6, and 12 weeks post-surgery for the 
RGD, PCL, and Empty Conduit groups. In 
addition, video captures from the isograft 
group were analyzed at 0, 2, and 6 weeks 
post-surgery. Gait abnormalities and poor 
video quality reduced the number of animals 
available for all four evaluation methods. In 
the original study, there were n = 20 in the 
RGD and PCL groups, n = 21 in the empty 
conduit group, and n= 12 in the isograft 
group. Toe contracture in prevented SFI 
evaluations in every group. Toe contracture 
was present in RGD n= 2, PCL n = 2, isograft 
n = 10, empty conduit n = 1. Missing or poor 
video quality excluded more animals from 
this study in isograft n = 6 and empty conduit 
n = 7 groups. These reductions in available 
videos resulted in each group having n = 5 
animals, which decreases the impact of the 
experiment.  
The ranges and means of the four 
evaluation methods for each group over time 
is presented in Figure 2. In SFI, each 
treatment group in weeks 0, 2, and 6 had a 
small range relative to the scale of the 
measurement. In week 12, the ranges of the 
PCL and RGD groups increased. For 
example, the standard deviation of the RGD 
group in week 0 was 4.9, while the standard 
deviation for week 12 was 21.1. SFI can be 
seen to increase over time for every group, 
indicating recovery.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Ranges and means of treatment groups over 12 week trial. The isograft group was 
evaluated over 6 weeks, while the RGD, PCL, and empty conduit groups were evaluated over 12 
weeks. A - Sciatic Functional Index. B - Imbalance coupling. C - Stance factor. D - Toe out angle 
A 
D C 
B 
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Table 1. Analysis of variance for each evaluation method. Factors tested include treatment method 
(RGD, PCL, empty conduit, and isograft), week (0-12), and subject. Significance was considered 
p<0.05. Weeks 0 - 12 did not include the isograft group, while weeks 0 - 6 included the isograft 
group. 
Weeks 0 - 6 Weeks 0 - 12 
Source Factor p-value Source Factor p-value 
SFI 
Treatment 0.518 
SFI 
Treatment 0.957 
Week 0.000 Week 0.000 
Subject 0.634 Subject 0.692 
IC 
Treatment 0.030 
IC 
Treatment 0.408 
Week 0.102 Week 0.205 
Subject 0.735 Subject 0.414 
SF 
Treatment 0.419 
SF 
Treatment 0.912 
Week 0.559 Week 0.093 
Subject 0.852 Subject 0.694 
TOA 
Treatment 0.111 
TOA 
Treatment 0.206 
Week 0.098 Week 0.655 
Subject 0.824 Subject 0.655 
 
In IC, most groups had relatively low 
variability, like the PCL group in week 0, 
with a mean and standard deviation of 0.95 ± 
0.07. The RGD group in week 2 and the 
empty conduit group in week 12 had higher 
variability. The mean and standard deviation 
for the RGD group in week 2 was 1.95 ± 1.14, 
while the mean and standard deviation of the 
empty conduit group in week 12 was 1.5 ± 
0.78. In SF, most groups over every time 
point had a large range relative to the scale of 
the measurement. The lowest standard 
deviation was in the RGD group in week 6, at 
1.01 ± 0.03. Contrastingly, the standard 
deviation was 5 times higher in the same 
group in week 2 at 1.12 ± 0.15.  In TOA, pre-
surgery evaluations had generally higher 
means and standard deviations than later 
evaluations. In the empty conduit group in 
week 0, the mean and standard deviation was 
0.98 ± 0.66. In the isograft group in week 6, 
the mean and standard deviation were 0.51 ± 
0.1. 
In a regression model, SFI over time 
had an R-squared value of 94.5%. IC, SF, and 
TOA had low R-squared values of 31.8%, 
27.6%, and 28.9%, respectively. 
In a Pearson correlation, shown in 
Table 2, imbalance coupling correlated 
significantly with SFI in both the 6 week and 
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12 week trials. Stance factor and imbalance 
coupling were correlated significantly in both 
the 6 and 12 week trials. Interestingly, 
although IC correlated with both SFI and SF, 
SF did not correlate with SFI. Stance factor 
and imbalance coupling may correlate 
because both measures were calculated from 
the exact same measurements of the videos.  
No significant difference was found 
between treatments or subjects in SFI, SF, or 
TOA. For SFI, 6 and 12 week trials both saw 
significant increases over time (p=0.00 for 
both). A Tukey pairwise comparison 
indicated that the Week 0 differed 
significantly from weeks 2, 6, and 12. Weeks 
2 and 6 were not significantly different, but 
week 12 was significantly different from the 
other weeks. This significant increase in SFI 
indicates recovery. For IC in the 6 week trial, 
a significant difference was found between 
treatment groups for all weeks and subjects 
(p=0.03). No significant difference was 
found between weeks or subjects. A Tukey 
pairwise comparison indicated a significant 
increase in the RGD group compared to the 
other groups. Pearson correlations examined 
for the 6 and 12 week trials were detailed in 
Table 2.  
 
Table 2. Pearson correlation coefficients and p-values define the degree of correlation between 
evaluation techniques. Weeks 0 - 12 did not include the isograft group, while weeks 0 - 6 included 
the isograft group. Significance was considered p<0.05. 
Weeks 0-6 Weeks 0-12 
Treatment Measure SFI IC SF Treatment Measure SFI IC SF 
IC Pearson 
coefficient 
-0.28   
  
  
  
  
  
IC Pearson 
coefficient 
-0.27   
  
  
  
  
  p-value 0.03 p-value 0.04 
SF Pearson 
coefficient 
-0.14 0.26 SF Pearson 
coefficient 
-0.08 0.4 
p-value 0.29 0.05 p-value 0.54 0.00 
TOA Pearson 
coefficient 
0.29 0.01 -0.03 TOA Pearson 
coefficient 
0.21 -0.09 -0.02 
p-value 0.02 0.97 0.8 p-value 0.11 0.51 0.86 
When evaluating up to 6 weeks of 
post-surgery, imbalance coupling was 
significantly different between treatments. A 
Tukey pairwise comparison indicated a 
significant increase between the RGD group 
and the other groups in week 2. The RGD 
animals had a wide variation (1.95 +/- 1.14), 
and this variation came almost entirely from 
one animal, despite not statistically 
qualifying as an outlier. Removing this 
animal brought the mean and standard 
deviation of the RGD group to 1.45 ± 0.29, 
which would be the highest average of any 
group. The next highest mean and standard 
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deviation was 1.2 ± 0.18 in the PCL group. It 
is reasonable to dismiss the significant 
increase between treatments in IC to be due 
to the one animal. 
 
DISCUSSION 
 
 In this study, four techniques were 
employed to quantify the functional return 
after peripheral nerve damage. The rat sciatic 
model was used to compare the nerve repair 
potential of two nanofiber conduits to an 
empty conduit and the current gold standard, 
an isograft. Video recordings of the animals 
on a walking track allowed for the evaluation 
of the sciatic functional index, imbalance 
coupling, stance factor, and toe out angle of 
the animals. Walking track analyses were 
conducted pre-surgery and 2, 6, and 12 weeks 
post-surgery. Sciatic functional index, the 
current standard for quantifying functional 
recovery, fails in certain conditions common 
to the rat sciatic model [9, 10]. While SFI 
fails in the presence of autotomy and toe 
contractures, imbalance coupling, stance 
factor, and toe out angle do not [7, 11, 10]. 
Gait velocity was not included as a covariate 
in the scope of this project. This study served 
to assess the value of the other walking track 
evaluation methods by determining which are 
correlated. 
Walking speed may be a confounding 
variable that affected SFI, imbalance 
coupling, and TOA. SFI has already been 
shown to vary significantly with speed in 
other studies [11]. Print length, the main 
component of SFI, is the main cause of this 
variation. Higher walking speeds result in 
shorter print lengths. Decreased print length 
correlates with lower SFI, indicating a return 
to healthy gait [11] This correlation would 
indicate that an animal walking slower in one 
trial has a more impaired gait than the same 
animal in another trial walking at a higher 
velocity. The problem arises, however, when 
considering factors not related to recovery 
that cause slow walking speed, like fatigue or 
the exploration of an unfamiliar area. 
Because of these flaws in SFI, this measure 
can misrepresent level of recovery when 
speed is not controlled. Contrasting with SFI, 
TOA has been shown to increase with 
walking speed [14].  While higher walking 
speed is correlated with recovery in SFI, it 
correlates with impairment in TOA. 
Coupling patterns between front and hind 
legs have been shown to vary significantly 
with walking speed [14].  Further verification 
is required to determine if its effect increases 
or decreases the measure. Stance factor is 
unaffected by walking speed because stance 
factor is intrinsically expressed as a ratio. 
Because SF is the ratio of the contact duration 
between the sham and experimental foot, the 
difference in walking speed between two 
different trials does not change the ratio. 
Further studies including gait velocity as a 
covariate are necessary when comparing 
these analysis methods. 
Poor video quality and toe contracture 
eliminated many videos and animals from the 
study. Although toe contracture did not 
eliminate animals from being evaluated with 
IC, TOA, and SF, it did prevent evaluation 
via SFI. To compare every evaluation method 
with the same animals, there were only n = 5 
animals per group. This small sample size 
reduced the impact of the present study. 
Further, certain tests had requirements that 
limited my ability to evaluate. Specifically, 
imbalance coupling required a minimum of 
four consecutive steps at a constant speed [7]. 
Animals with recently severed sciatic nerves 
frequently take just one or two steps before 
resting. For many animals, out of ten or more 
videos, only one instance of four consecutive 
steps could be captured. If the data from this 
set of steps was an outlier, it was impossible 
to check other data from that animal to 
determine if the outlier was caused by a larger 
pattern or a one-time abnormality. In certain 
cases, measurement was taken on the last step 
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before the animal came to a halt. This change 
in velocity could cause the animal’s gait to 
differ slightly than when in continuous 
motion. When the animal is coming to a halt, 
it may not swing its leg as far. This change 
would result in a shorter stance duration, 
causing SF to decrease and IC to increase and 
skew the data compared to trials where the 
animal took 4 or more steps at a constant 
speed. 
The low R-squared values of IC, 
TOA, and SF compared to time indicate that 
the time point in the study is not able to 
predict the evaluation method scores. 
Because the evaluation method scores 
indicated recovery level, it is impossible for 
the time point in this study to indicate how 
recovered the animal is. This low regression 
value is due to a high variation in evaluation 
method scores. This large variation could be 
because of the small sample size or velocity 
variability and does not exclude these 
evaluation methods from further studies with 
higher sample sizes. 
Based on the results here, changes in 
protocol in future walking track evaluations 
could better reveal the ability of these 
evaluation methods to quantify functional 
recovery. Direct lighting and a higher speed 
camera will improve accuracy in 
measurements. Toe out angle accuracy would 
be improved by using dye to mark the midline 
of the animal. The most important change to 
the protocol to increase the impact of this 
study would be the incorporation of a 
treadmill in the walking track analysis. 
Because three out of the four evaluation 
methods are affected by speed variability, it 
is difficult to draw any firm conclusions 
about them when speed is not controlled. 
While this method may be more expensive, it 
is feasible. For example, Jacobs, et al., 2018 
[15] uses an open source GAITOR Suite 
while Deumens, et al., 2007 [16] uses 
CatWalk gait analysis in their sciatic rat 
model. Lastly, if treadmills are not 
implemented, the study could be improved by 
motivating the animals to walk across the 
track without pause. Conducting testing prior 
to feeding time and placing food at the end of 
the track would also motivate the animals to 
walk across the track without pause. These 
additions will reduce the length of time 
required to get a video with usable data.  
 
CONCLUSIONS 
 
This study served to assess the 
potential of four techniques to quantify the 
functional return after nerve damage. Video 
walking track analysis allowed for a 
retrospective evaluation of the sciatic 
functional index, imbalance coupling, stance 
factor, and toe out angle. Imbalance coupling 
showed promising correlation with the 
current industry standard, the sciatic 
functional index. Future investigation with 
updated protocol is necessary to confirm the 
degree of correlation and to evaluate the 
potential for a new industry standard for 
evaluating nerve repair. 
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